BAM
GILD icon

BOCHK Asset Management’s Gilead Sciences GILD Stock Holding History

BOCHK Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
+19,800
New +$2.61M 0.39% 68
2026
Q1 		– Sell
-250
Closed -$30.7K – 127
2025
Q4 		$30.7K Buy
+250
New +$30.4K 0.01% 72

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOCHK Asset Management's GILD Position: Q2 2026 in Review

BOCHK Asset Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 19,800 shares worth $2.5M. The stake represents 0.39% of the portfolio and ranks #68 among its holdings. This is a return to the name: BOCHK Asset Management previously reported a position in GILD as recently as Q4 2025.

BOCHK Asset Management first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BOCHK Asset Management held 19,800 shares of Gilead Sciences worth $2.5M as of Q2 2026.
  • Gilead Sciences was a new BOCHK Asset Management position in Q2 2026.
  • Gilead Sciences made up 0.39% of BOCHK Asset Management's portfolio in Q2 2026, its #68 holding.
  • BOCHK Asset Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BOCHK Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.